[1]
Paucar, C.A., Alvarado-Huayhuaz, J.A., Vega, H.R.G., Rocio, R.P., Peralta, M.Z., Cortavarria, P.S. and Negrón, A.V. 2026. Pyrazinamide-derived hydrazone outperforms pyrazinamide activity in Mycobacterium tuberculosis DM97: an in vitro and in silico study. Eclética Química. 51, (Jun. 2026), e–1506. DOI:https://doi.org/10.26850/1678-4618.eq.v51.2026.e1506.